KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Non-Current Deffered Revenue (2020 - 2025)

Ginkgo Bioworks Holdings' Non-Current Deffered Revenue history spans 6 years, with the latest figure at $75.2 million for Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue fell 23.89% year-over-year to $75.2 million; the TTM value through Dec 2025 reached $75.2 million, down 23.89%, while the annual FY2025 figure was $75.2 million, 23.89% down from the prior year.
  • Non-Current Deffered Revenue reached $75.2 million in Q4 2025 per DNA's latest filing, up from $74.1 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $179.9 million in Q2 2023 to a low of $18.7 million in Q4 2021.
  • Average Non-Current Deffered Revenue over 5 years is $102.4 million, with a median of $89.6 million recorded in 2024.
  • The largest YoY upside for Non-Current Deffered Revenue was 832.29% in 2022 against a maximum downside of 87.12% in 2022.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $18.7 million in 2021, then skyrocketed by 832.29% to $174.8 million in 2022, then decreased by 9.56% to $158.1 million in 2023, then crashed by 37.5% to $98.8 million in 2024, then dropped by 23.89% to $75.2 million in 2025.
  • Per Business Quant, the three most recent readings for DNA's Non-Current Deffered Revenue are $75.2 million (Q4 2025), $74.1 million (Q3 2025), and $74.6 million (Q2 2025).